Granted Patent
Utility
US 6,573,273
· Confirmation No. 2666
UREA SUBSTITUTED IMIDAZOQUINOLINES
Patented Case
View Patent ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2012-02-15 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2012-02-15 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2012-02-07 | PA.. |
Power of Attorney | 1 | View | |
| 2012-02-07 | R3.73 |
Assignee showing of ownership per 37 CFR 3.73 | 1 | View | |
| 2012-02-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2012-02-07 | LET. |
Miscellaneous Incoming Letter | 2 | View | |
| 2001-12-21 | TRNA |
Transmittal of New Application | 2 | View | |
| 2001-12-21 | SPEC |
Specification | 109 | View | |
| 2001-12-21 | CLM |
Claims | 7 | View | |
| 2001-12-21 | ABST |
Abstract | 1 | View |
Inventors
Stephen L. Crooks
Mahtomedi, MN
George W. Griesgraber
Eagan, MN
Kyle J. Lindstrom
Houlton, WI
Bryon A. Merrill
River Falls, WI
Michael J. Rice
Oakdale, MN
Attorneys & Agents of Record
Classification
USPC
514/293
C07D471/04
A61P1/02
A61P37/02
A61P31/00
A61P43/00
A61P11/06
A61P31/12
A61P37/08
Y02A50/30
A61P27/16
A61P31/10
A61P35/00
A61K31/4745
Prosecution
- Examiner
- AULAKH, CHARANJIT
- Art Unit
- 1625
- Customer No.
- 11903
- Docket No.
- FMRXRQD02P19990610AUSX01
- Confirmation No.
- 2666
Patent Term Adjustment
-91days
Parent
is a Continuation in-part of
→
App. 09/589,236
· US 6,541,485
Filed 2000-06-07
· Patented Case
Parent
Claims priority from a provisional application
→
App. 60/138,365
Filed 1999-06-10
· Provisional Application Expired
Child
is a Continuation of
→
App. 10/780,379
· US 6,897,221
Filed 2004-02-17
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
Child
is a Continuation of
→
App. 10/370,800
· US 6,784,188
Filed 2003-02-20
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
Child
is a Continuation of
→
App. 11/038,434
· US 7,157,453
Filed 2005-01-20
· Patented Case
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH US, LLC,
SOLTA MEDICAL, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2019-03-11
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
NOTICE OF SUCCESSION OF AGENCY
Recorded 2015-01-09
SECURITY AGREEMENT
Recorded 2013-04-24
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2011-12-13
SECOND LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-05-11
RELEASE OF FIRST LIEN SECURITY AGREEMENT IN PATENTS
Recorded 2007-05-10
RELEASE OF SECOND LIEN SECURITY AGREEMENT IN PATENTS
Recorded 2007-05-10
FIRST LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-05-10
SECOND LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-03-23
FIRST LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-03-21
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2007-02-08
from
CROOKS, STEPHEN L.,
GRIESGRABER, GEORGE W.,
LINDSTROM, KYLE J.,
MERRILL, BRYON A.,
RICE, MICHAEL J.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2002-06-12
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- Patent No.
- US 6,573,273
- App. No.
- 10/028,255
- Filed
- 2001-12-21
- Granted
- 2003-06-03
- Examiner
- AULAKH, CHARANJIT
- Art Unit
- 1625
- PTA
- -91 days
External Links